{
  "pmcid": "2745838",
  "sha256": "ab75e93ab3e76e4f595999ee8ff4fcf5ad01b5bff64221bc93f463efca869146",
  "timestamp_utc": "2025-11-09T23:46:06.914121+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.447570281124502,
    "reading_ease": 16.119467871485966,
    "word_count": 249
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Continuous Posterior Interscalene Block for Postoperative Analgesia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised, triple-masked, placebo-controlled trial"
      },
      "Participants": {
        "score": 1,
        "evidence": "32 participants were enrolled"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either a continuous ropivacaine 0.2% perineural infusion or a normal saline infusion"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates whether an ultrasound-guided continuous posterior interscalene block offers superior postoperative analgesia compared to a single-injection ropivacaine interscalene block after moderately painful shoulder surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was average pain on postoperative day (POD) 1, assessed on a 0–10 scale."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was maintained for patients, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "32 participants were enrolled and randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "30 were analysed per protocol (15 in each group)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Continuous ropivacaine infusion resulted in a significant reduction in average pain on POD 1 (median [10th–90th percentile]: 0.0 [0.0–5.0] vs. 3.0 [0.0–6.0]; P < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were observed."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Registration Number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of Funding]."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}